Shannon J. Sirk

1.7k total citations
23 papers, 1.3k citations indexed

About

Shannon J. Sirk is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, Shannon J. Sirk has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Genetics. Recurrent topics in Shannon J. Sirk's work include CRISPR and Genetic Engineering (9 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and RNA Interference and Gene Delivery (4 papers). Shannon J. Sirk is often cited by papers focused on CRISPR and Genetic Engineering (9 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and RNA Interference and Gene Delivery (4 papers). Shannon J. Sirk collaborates with scholars based in United States, China and Japan. Shannon J. Sirk's co-authors include Thomas Gaj, Carlos F. Barbas, Jia Liu, Yoshio Kato, Jing Guo, Anna M. Wu, Tove Olafsen, Andrew C. Mercer, James T Patterson and Bhaswati Barat and has published in prestigious journals such as Cell, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Shannon J. Sirk

23 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shannon J. Sirk United States 18 995 273 187 143 122 23 1.3k
Andrew P. May United States 17 1.5k 1.5× 347 1.3× 46 0.2× 109 0.8× 97 0.8× 23 1.7k
Quinn Lu United States 19 1.3k 1.3× 232 0.8× 66 0.4× 129 0.9× 288 2.4× 35 1.5k
Helene Faustrup Kildegaard Denmark 27 2.0k 2.0× 579 2.1× 386 2.1× 41 0.3× 179 1.5× 53 2.1k
Fatemeh Safari Iran 14 483 0.5× 89 0.3× 69 0.4× 56 0.4× 64 0.5× 35 757
Seung‐Joo Lee United States 14 1.0k 1.1× 286 1.0× 25 0.1× 76 0.5× 80 0.7× 26 1.2k
An Xiao United States 17 1.0k 1.0× 213 0.8× 45 0.2× 154 1.1× 33 0.3× 38 1.3k
Derek Jantz United States 15 980 1.0× 263 1.0× 11 0.1× 308 2.2× 254 2.1× 21 1.2k
Daniel Bojar Sweden 15 1.3k 1.3× 70 0.3× 96 0.5× 128 0.9× 95 0.8× 39 1.5k
Kevin T. Zhao United States 15 2.5k 2.6× 726 2.7× 20 0.1× 419 2.9× 95 0.8× 25 2.7k

Countries citing papers authored by Shannon J. Sirk

Since Specialization
Citations

This map shows the geographic impact of Shannon J. Sirk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shannon J. Sirk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shannon J. Sirk more than expected).

Fields of papers citing papers by Shannon J. Sirk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shannon J. Sirk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shannon J. Sirk. The network helps show where Shannon J. Sirk may publish in the future.

Co-authorship network of co-authors of Shannon J. Sirk

This figure shows the co-authorship network connecting the top 25 collaborators of Shannon J. Sirk. A scholar is included among the top collaborators of Shannon J. Sirk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shannon J. Sirk. Shannon J. Sirk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sirk, Shannon J., et al.. (2024). A molecular toolkit for heterologous protein secretion across Bacteroides species. Nature Communications. 15(1). 9741–9741. 3 indexed citations
2.
Sirk, Shannon J., et al.. (2022). Short FcRn-Binding Peptides Enable Salvage and Transcytosis of scFv Antibody Fragments. ACS Chemical Biology. 17(2). 404–413. 5 indexed citations
3.
Sirk, Shannon J., Andrew P. Klein, Curt R. Fischer, et al.. (2020). A Metabolic Pathway for Activation of Dietary Glucosinolates by a Human Gut Symbiont. Cell. 180(4). 717–728.e19. 108 indexed citations
4.
Sirk, Shannon J., et al.. (2020). Living Therapeutics: The Next Frontier of Precision Medicine. ACS Synthetic Biology. 9(12). 3184–3201. 19 indexed citations
5.
Gaj, Thomas, et al.. (2016). Genome-Editing Technologies: Principles and Applications. Cold Spring Harbor Perspectives in Biology. 8(12). a023754–a023754. 241 indexed citations
6.
Gaj, Thomas, et al.. (2014). Protein Delivery Using Cys 2 –His 2 Zinc-Finger Domains. ACS Chemical Biology. 9(8). 1662–1667. 48 indexed citations
7.
Liu, Jia, Thomas Gaj, James T Patterson, Shannon J. Sirk, & Carlos F. Barbas. (2014). Cell-Penetrating Peptide-Mediated Delivery of TALEN Proteins via Bioconjugation for Genome Engineering. PLoS ONE. 9(1). e85755–e85755. 119 indexed citations
8.
Gaj, Thomas, et al.. (2014). Enhancing the Specificity of Recombinase-Mediated Genome Engineering through Dimer Interface Redesign. Journal of the American Chemical Society. 136(13). 5047–5056. 22 indexed citations
9.
Gaj, Thomas, Andrew C. Mercer, Shannon J. Sirk, Heather Smith, & Carlos F. Barbas. (2013). A comprehensive approach to zinc-finger recombinase customization enables genomic targeting in human cells. Nucleic Acids Research. 41(6). 3937–3946. 38 indexed citations
10.
Gaj, Thomas, Shannon J. Sirk, & Carlos F. Barbas. (2013). Expanding the scope of site‐specific recombinases for genetic and metabolic engineering. Biotechnology and Bioengineering. 111(1). 1–15. 69 indexed citations
11.
Gavrilyuk, Julia, Hitoshi Ban, Hisatoshi Uehara, et al.. (2013). Antibody Conjugation Approach Enhances Breadth and Potency of Neutralization of Anti-HIV-1 Antibodies and CD4-IgG. Journal of Virology. 87(9). 4985–4993. 20 indexed citations
12.
Olafsen, Tove, et al.. (2012). ImmunoPET using engineered antibody fragments: fluorine-18 labeled diabodies for same-day imaging. Tumor Biology. 33(3). 669–677. 51 indexed citations
13.
Gaj, Thomas, Jing Guo, Yoshio Kato, Shannon J. Sirk, & Carlos F. Barbas. (2012). Targeted gene knockout by direct delivery of zinc-finger nuclease proteins. Nature Methods. 9(8). 805–807. 232 indexed citations
14.
Liu, Kan, Eric J. Lepin, Feng Guo, et al.. (2011). Microfluidic-based 18F-labeling of biomolecules for immuno-positron emission tomography.. PubMed. 10(3). 168–76, 1. 36 indexed citations
15.
Liu, Kan, Eric J. Lepin, Mingwei Wang, et al.. (2011). Microfluidic-Based 18F-Labeling of Biomolecules for Immuno–Positron Emission Tomography. Molecular Imaging. 10(3). 25 indexed citations
16.
Olafsen, Tove, Shannon J. Sirk, David J. Betting, et al.. (2010). ImmunoPET imaging of B-cell lymphoma using 124I-anti-CD20 scFv dimers (diabodies). Protein Engineering Design and Selection. 23(4). 243–249. 35 indexed citations
17.
Barat, Bhaswati, Shannon J. Sirk, Katelyn E. McCabe, et al.. (2009). Cys-diabody Quantum Dot Conjugates (ImmunoQdots) for Cancer Marker Detection. Bioconjugate Chemistry. 20(8). 1474–1481. 49 indexed citations
18.
Sirk, Shannon J., Clifton Kwang-Fu Shen, Eric J. Lepin, et al.. (2009). MicroPET imaging of HER2+ tumors using F-18-labeled anti-HER2 diabody. 50. 492–492. 1 indexed citations
19.
Sirk, Shannon J., et al.. (2008). Site-Specific, Thiol-Mediated Conjugation of Fluorescent Probes to Cysteine-Modified Diabodies Targeting CD20 or HER2. Bioconjugate Chemistry. 19(12). 2527–2534. 42 indexed citations
20.
Lambert, James L., M. J. Pelletier, John Michael Morookian, et al.. (2006). Measurement of Amphotericin B concentration by Resonant Raman Spectroscopy – a novel technique that may be useful for non-invasive monitoring. Medical Mycology. 44(2). 169–174. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026